The expression levels of PLOD2 were also significantly higher in the tumors with deep myometrial invasion (>1/2 myometrial depth) (5.14 vs. 3.79, p = 0.041, one-way ANOVA) and higher histological grade (G3) (G1, 3.46 vs. G2, 5.28 vs. G3, 6.25, p = 0.039, one-way ANOVA) compared to those with superficial myometrial invasion (<1/2 myometrial invasion) and lower histological grades (G1 and G2) among the patients with endometrial adenocarcinoma (Table 3). This evidence concerns the gene PLOD2 and endometrium adenocarcinoma.